Press release
Gallbladder Neoplasms Treatment Market Size in the 7MM is expected to increase a significant CAGR by the forecast period of 2023-2032, estimates DelveInsight | EMD Serono Research & Development Institute Inc., Redx Pharma Ltd, Compass Therapeutics, Daiich
Gallbladder Neoplasms Market
Discover which therapies are expected to grab the Gallbladder Neoplasms Market Share @ Gallbladder Neoplasms Market Outlook- https://www.delveinsight.com/sample-request/gallbladder-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Gallbladder Neoplasms Market Report
• In March 2025. Redx Pharma Ltd announced a study is to evaluate the preliminary efficacy and safety of RXC004 monotherapy and in combination with pembrolizumab in advanced solid tumours that have progressed following SoC treatment.
• In March 2025, Lisata Therapeutics, Inc. conducted a study of clinical trial is to test a new drug plus standard treatment compared with standard treatment alone in patients with previously untreated cholangiocarcinoma or those that have progressed after first-line treatment for cholangiocarcinoma.
• In March 2025, Jazz Pharmaceuticals announced a study will first evaluate the safety and tolerability of ZW25 plus standard first-line combination chemotherapy (XELOX, FP, or mFOLFOX6 for GEA; mFOLFOX6 with or without bevacizumab for CRC; and CisGem for BTC) and will confirm the recommended dosage (RD) of ZW25 when administered in combination with each of these multi-agent chemotherapy regimens. Then, Part 2 of the study will evaluate the anti-tumor activity of ZW25 plus combination chemotherapy in HER2-expressing GEA, BTC, and CRC.
• The increase in Gallbladder Neoplasms Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Gallbladder Neoplasms Market is anticipated to witness growth at a considerable CAGR.
• The leading Gallbladder Neoplasms Companies such as EMD Serono Research & Development Institute Inc., Redx Pharma Ltd, Compass Therapeutics, Daiichi Sankyo, Merck Sharp & Dohme LLC, Jazz Pharmaceuticals, Genzyme, a Sanofi Company, Intima Bioscience Inc., Tango Therapeutics Inc. and others.
• Promising Gallbladder Neoplasms Pipeline Therapies such as Panitumumab, Oxaliplatin, Gemcitabine, Cisplatin, Copanlisib, Capecitabine, Bevacizumab and others.
Stay ahead in the Gallbladder Neoplasms Therapeutics Market with DelveInsight's Strategic Report @ Gallbladder Neoplasms Market Outlook- https://www.delveinsight.com/sample-request/gallbladder-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Gallbladder Neoplasms Epidemiology Segmentation in the 7MM
The epidemiology section of Gallbladder Neoplasms offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Gallbladder Neoplasms Epidemiology trends @ Gallbladder Neoplasms Prevalence- https://www.delveinsight.com/sample-request/gallbladder-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Gallbladder Neoplasms Drugs Market
The Gallbladder Neoplasms Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Gallbladder Neoplasms signaling in Gallbladder Neoplasms are likely to uncover new therapeutic targets and further expand treatment options for patients.
Gallbladder Neoplasms Treatment Market Landscape
The Gallbladder Neoplasms treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Gallbladder Neoplasms has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about Gallbladder Neoplasms treatment guidelines, visit @ Gallbladder Neoplasms Treatment Market Landscape- https://www.delveinsight.com/sample-request/gallbladder-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Gallbladder Neoplasms Market Outlook
The report's outlook on the Gallbladder Neoplasms market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Gallbladder Neoplasms therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Gallbladder Neoplasms drug and late-stage pipeline therapy.
Gallbladder Neoplasms Drugs Uptake
The drug chapter of the Gallbladder Neoplasms report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Gallbladder Neoplasms.
Major Gallbladder Neoplasms Companies
EMD Serono Research & Development Institute Inc., Redx Pharma Ltd, Compass Therapeutics, Daiichi Sankyo, Merck Sharp & Dohme LLC, Jazz Pharmaceuticals, Genzyme, a Sanofi Company, Intima Bioscience Inc., Tango Therapeutics Inc. and others.
Learn more about the FDA-approved drugs for Gallbladder Neoplasms @ Drugs for Gallbladder Neoplasms Treatment- https://www.delveinsight.com/sample-request/gallbladder-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Gallbladder Neoplasms Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Gallbladder Neoplasms Companies- EMD Serono Research & Development Institute Inc., Redx Pharma Ltd, Compass Therapeutics, Daiichi Sankyo, Merck Sharp & Dohme LLC, Jazz Pharmaceuticals, Genzyme, a Sanofi Company, Intima Bioscience Inc., Tango Therapeutics Inc. and others.
• Gallbladder Neoplasms Pipeline Therapies- Panitumumab, Oxaliplatin, Gemcitabine, Cisplatin, Copanlisib, Capecitabine, Bevacizumab and others.
• Gallbladder Neoplasms Market Dynamics: Gallbladder Neoplasms Market Drivers and Barriers
• Gallbladder Neoplasms Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Gallbladder Neoplasms Drugs in development @ Gallbladder Neoplasms Clinical Trials Assessment- https://www.delveinsight.com/sample-request/gallbladder-neoplasms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Executive Summary of Gallbladder Neoplasms
3. Competitive Intelligence Analysis for Gallbladder Neoplasms
4. Gallbladder Neoplasms: Market Overview at a Glance
5. Gallbladder Neoplasms: Disease Background and Overview
6. Patient Journey
7. Gallbladder Neoplasms Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Gallbladder Neoplasms Unmet Needs
10. Key Endpoints of Gallbladder Neoplasms Treatment
11. Gallbladder Neoplasms Marketed Products
12. Gallbladder Neoplasms Emerging Therapies
13. Gallbladder Neoplasms: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Gallbladder Neoplasms
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
List of Top Selling Market Research Reports in 2025
Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gallbladder Neoplasms Treatment Market Size in the 7MM is expected to increase a significant CAGR by the forecast period of 2023-2032, estimates DelveInsight | EMD Serono Research & Development Institute Inc., Redx Pharma Ltd, Compass Therapeutics, Daiich here
News-ID: 3921687 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Gallbladder
Gallbladder Neoplasms Market Emerging Trends and Growth Prospects 2034
Introduction
Gallbladder neoplasms are rare but aggressive malignancies arising in the biliary tract, most often diagnosed at advanced stages due to their asymptomatic progression. With high mortality rates and limited curative options, gallbladder cancers represent a major clinical challenge in hepatobiliary oncology. The condition is more prevalent in certain regions such as South America, Eastern Europe, and South Asia, where genetic predisposition, gallstone disease, and chronic inflammation contribute to elevated risk.
Traditional…
Gallbladder Neoplasms Market Emerging Trends and Growth Prospects 2034
Introduction
Gallbladder neoplasms are rare but aggressive malignancies arising in the biliary tract, most often diagnosed at advanced stages due to their asymptomatic progression. With high mortality rates and limited curative options, gallbladder cancers represent a major clinical challenge in hepatobiliary oncology. The condition is more prevalent in certain regions such as South America, Eastern Europe, and South Asia, where genetic predisposition, gallstone disease, and chronic inflammation contribute to elevated risk.
Traditional…
Gallbladder Cancer Treatment Market Expands With Emergence of Novel Chemotherape …
Gallbladder Cancer Treatment Market Overview
The Gallbladder Cancer Treatment Market is projected to grow from USD 720 Million in 2025 to USD 1.4 Billion by 2032, at a CAGR of 10.1% during the forecast period.
Coherent Market Insights is pleased to release its latest Gallbladder Cancer Treatment Market research report, offering an in-depth analysis of the U.S. Gallbladder Cancer Treatment Market Landscape from 2025 to 2032. This report delivers reliable projections across…
Gallbladder Cancer Market to Rise by 2032 | Celgene, MedImmune, Ohara Pharmaceut …
DelveInsight's "Gallbladder Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Gallbladder Cancer, historical and forecasted epidemiology as well as the Gallbladder Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Gallbladder Cancer market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Gallbladder Cancer market size…
Gallbladder Cancer Market Size, Share Report and Forecast 2024-2032
The gallbladder cancer market size was valued at USD 87.57 million in 2023, driven by the increasing research and development activities for new treatment among people across the major markets. The market size is anticipated to grow at a CAGR of 5.56% during the forecast period of 2024-2032 to achieve a value of USD 142.5 million by 2032.
Gallbladder Cancer: Introduction
Gallbladder cancer is a rare and often aggressive malignancy that forms…
Gallbladder Cancer Therapeutics Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Gallbladder Cancer Therapeutics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Gallbladder Cancer Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.…
